Should publications that post op-ed pieces tell us more about who wrote the op-ed and what their potential biases and conflicts of interest might be? I’m in the camp that answers a resounding YES. Till Bruckner is, too. He writes for Transparify, an organization that rates “the financial transparency of major think tanks.” He is… Read More: Transparency watchdog criticizes STAT’s non-disclosure on pro-Pharma op-ed »
Dive Brief: The leaders of the Senate HELP Committee on Thursday proposed a wide-ranging and ambitious package of healthcare bills, including measures addressing surprise medical billing, price transparency, interoperability, drug costs and public health. One bill put forward would require commercial insurers to make claims data and expected out-of-pocket costs available to patients through application… Read More: Senate health committee takes on surprise bills, price transparency in… »
Dive Brief: Senate Finance Committee Ranking Member Ron Wyden, D-Ore., introduced a bill Wednesday that would require health insurers to tell beneficiaries what the out-of-pocket costs would be for any in-network procedure or prescription drug they seek. The Health Care Price Check Act stipulates that commercial insurers, as well as Medicare plans, provide an online tool… Read More: Wyden introduces price transparency bill targeting payers »
Seema Verma, administrator of the Centers for Medicare and Medicaid Services, wants healthcare providers to improve their cost transparency as patients need to know the price they will pay for their treatments. “Can you imagine going to the grocery store, getting the groceries you need for a week, but never knowing the price of your… Read More: CMS doubles down on Medicare price transparency efforts »